Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview

Quinidine gluconate - Generic Drug Details

« Back to Dashboard

What are the generic sources for quinidine gluconate and what is the scope of quinidine gluconate patent protection?

Quinidine gluconate
is the generic ingredient in six branded drugs marketed by Watson Labs, Warner Chilcott, Lilly, Cycle Pharms Ltd, Sun Pharm Inds, Bayer Hlthcare, Superpharm, Halsey, Lannett, Ascot, and Aurolife Pharma Llc, and is included in fifteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-six drug master file entries for quinidine gluconate. Four suppliers are listed for this compound.

Summary for Generic Name: quinidine gluconate

Tradenames:6
Patents:1
Applicants:11
NDAs:15
Drug Master File Entries: see list26
Suppliers / Packagers: see list4
Bulk Api Vendors: see list19
Clinical Trials: see list67
Patent Applications: see list1,122
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:quinidine gluconate at DailyMed

Pharmacology for Ingredient: quinidine gluconate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ascot
QUINIDINE GLUCONATE
quinidine gluconate
TABLET, EXTENDED RELEASE;ORAL088582-001Jun 17, 1985DISCNNoNo► Subscribe► Subscribe
Bayer Hlthcare
QUINAGLUTE
quinidine gluconate
TABLET, EXTENDED RELEASE;ORAL016647-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Bayer Hlthcare
QUINACT
quinidine gluconate
TABLET;ORAL086099-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Halsey
QUINIDINE GLUCONATE
quinidine gluconate
TABLET, EXTENDED RELEASE;ORAL089476-001Apr 10, 1987DISCNNoNo► Subscribe► Subscribe
Superpharm
QUINIDINE GLUCONATE
quinidine gluconate
TABLET, EXTENDED RELEASE;ORAL089164-001Nov 21, 1985DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Formulary management
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot